Methicillin-resistant staphylococcus aureus: The most prevalent cause of ventilator associated pneumonia in Tehran hospitals

A. Ghodousi, M. Omrani, M. M. Feizabadi (Tehran, Islamic Republic Of Iran)

Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Session: Different interesting issues in respiratory infections: 1
Session type: Thematic Poster Session
Number: 2558
Disease area: Respiratory critical care, Respiratory infections

Congress or journal article abstract

Abstract

IntroductionMethicillin-resistant Staphylococcus aureus(MRSA) assumes paramount importance in nosocomial pneumonia, particularly in mechanically ventilated patients. The mortality rate due to MRSA infections is highest among pneumonia cases.ObjectivesThe aim of this study was to characterize the antibiotic resistance pattern and to detect outbreak strains isolated from the teaching hospitals of Tehran. This can help physicians to start appropriate initial therapy in patients with suspected nosocomial pneumonia.Methods269 lower respiratory tract (LTR) samples were collected from ICUs of three teaching hospitals in Tehran,Iran, during 2009 –2011.A semi-quantitative threshold of >104 cfu/ml was considered to be diagnostic for S. aureus ventilator associated pneumonia(VAP). Antibacterial resistance patterns of S. aureus isolates to 13 antimicrobial agents were analyzed according to EUCAST. Pulsed Field Gel Electrophoresis was performed as described previously (Feizabadi, M.M. et al. J Microbiol Methods 2011; 84:144 –146).Results Of 269 cultured LRT specimens 84 yielded S. aureus >104 cfu/ml. Oxacillin and vancomycin resistances were seen in 80.9% and 12.3% of isolates, respectively. Linezolid, teicoplanin and vancomycin were found to be the most effective drugs. Seventeen different DNA banding patterns were identified, which grouped in 4 clusters named as A-D.Discussion Mechanical ventilation is one of the most important risk factors for nosocomial MRSA pneumonia. MRSA-VAP ranged between 78 % in Asian and 54 % in Latin American ICUs. Consistently, in our study prevalence of methicillin resistance was 80.5%. This is the first report on S. aureus VAP from Iran.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Ghodousi, M. Omrani, M. M. Feizabadi (Tehran, Islamic Republic Of Iran). Methicillin-resistant staphylococcus aureus: The most prevalent cause of ventilator associated pneumonia in Tehran hospitals. Eur Respir J 2014; 44: Suppl. 58, 2558

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Multidrug resistant acinetobacter baumannii in ventilator associated pneumonia: Prevalence and predictors of mortality
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014

MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia
Source: Eur Respir J 2009; 34: 1470-1476
Year: 2009



Factors associated with mortality in ventilator associated pneumonia of multidrug resistant acinetobacter baumannii
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Bundles for the prevention of ventilator-associated pneumonia in a Brazilian hospital
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Implications of identifying the pathogen in ventilator-associated pneumonia (VAP)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013


Ventilator-associated pneumonia (VAP) – Early and late-onset differences
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013


Microbiological vs non-microbiological confirmed nnventilator ICU-acquired pneumonia
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Nursing and healthcare-associated pneumonia requiring hospital admission: Microbiology and clinical outcomes
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Efficacy of ceftobiprole in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014

Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009



Carbapenemase producing Klebsiella pneumoniae (KPC+) colonization/infection in a respiratory intensive care unit: Prevalence, length of stay(LOS) and mortality
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014

Prognostic factors of the patients admitted to intensive care unit with nursing and healthcare-associated pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015

Health care-associated pneumonia and community-acquired pneumonia: A single-center experience
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015

Physical deterioration during hospitalization in patients with community-acquired pneumonia
Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions
Year: 2015


Prevention of nosocomial infections in acute respiratory failure patients
Source: Eur Respir J 2003; 22: 72S-76S
Year: 2003



Severe community-acquired pneumonia in alcoholic patients hospitalized in intensive care unit
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Can the broad-spectrum antibiotics improve the prognoses of high-risk nursing- and healthcare-associated pneumonia?
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


ICU acquired pneumonia due to pseudomonas aeruginosa with and without multidrug resistance
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014


Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia
Source: Eur Respir J 2006; 27: 1210-1216
Year: 2006



Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome
Source: Eur Respir J 2002; 20: 1483-1489
Year: 2002